This post was originally published on this site.

WASHINGTON – The U.S. Department of Labor’s Office of Workers’ Compensation Programs today announced it is expanding the pharmacy benefit improvements under the Federal Employees’ Compensation Act program to include more beneficiaries, protect worker benefits, and dramatically improve drug pricing transparency.This expansion will build upon the improvements made to the Federal Employees’ Compensation Act program initiated during the first Trump Administration and will now serve claimants under the Black Lung Benefits Act, Longshore and Harbor Workers’ Compensation Act, and Energy Employees Occupational Illness Compensation Program Act. It will also allow the federal government to benefit from cost savings from pharmaceutical